These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23981382)

  • 1. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
    Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
    Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
    Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.
    Ruiz-Lafuente N; Alcaraz-García MJ; Sebastián-Ruiz S; Gómez-Espuch J; Funes C; Moraleda JM; García-Garay MC; Montes-Barqueros N; Minguela A; Álvarez-López MR; Parrado A
    PLoS One; 2014; 9(10):e109533. PubMed ID: 25280001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
    Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
    Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
    Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
    Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.
    Messmer D; Fecteau JF; O'Hayre M; Bharati IS; Handel TM; Kipps TJ
    Blood; 2011 Jan; 117(3):882-9. PubMed ID: 21079155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
    McCaig AM; Cosimo E; Leach MT; Michie AM
    Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70.
    Lafarge ST; Hou S; Pauls SD; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2015 Jul; 39(7):773-8. PubMed ID: 26002513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
    Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
    Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.
    Ringshausen I; Oelsner M; Weick K; Bogner C; Peschel C; Decker T
    Leukemia; 2006 Mar; 20(3):514-20. PubMed ID: 16437144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.
    Secchiero P; di Iasio MG; Gonelli A; Barbarotto E; Melloni E; Tiribelli M; Chiaruttini C; Zauli G
    J Cell Physiol; 2007 Oct; 213(1):229-36. PubMed ID: 17476690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
    López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
    Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.
    Marquez ME; Deglesne PA; Suarez G; Romano E
    Int J Lab Hematol; 2011 Apr; 33(2):194-200. PubMed ID: 20942870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.
    Plander M; Seegers S; Ugocsai P; Diermeier-Daucher S; Iványi J; Schmitz G; Hofstädter F; Schwarz S; Orsó E; Knüchel R; Brockhoff G
    Leukemia; 2009 Nov; 23(11):2118-28. PubMed ID: 19657365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
    Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
    Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
    Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
    Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
    Balakrishnan K; Peluso M; Fu M; Rosin NY; Burger JA; Wierda WG; Keating MJ; Faia K; O'Brien S; Kutok JL; Gandhi V
    Leukemia; 2015 Sep; 29(9):1811-22. PubMed ID: 25917267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.